Article Text

This article has a correction. Please see:

Download PDFPDF
Medicines update

Statistics from Altmetric.com

The points below highlight changes in marketing authorisations (MAs) that may have a significant impact on veterinary surgeons’ prescribing decisions.

New marketing authorisations

New marketing authorisations relevant to veterinary surgeons in the UK that were issued or published in January 2019 are listed in Table 1.

View this table:
Table 1: Marketing authorisations issued and/or published in January 2019

Table 1 also indicates where a public assessment report should become available for a product. Where available, links to these reports are accessible by clicking on the relevant product on the VMD’s Product Information Database www.gov.uk/check-animal-medicine-licensed

The European Medicines Agency publishes European Public Assessment Reports for every veterinary medicine that is authorised through a centralised procedure. Links to these reports are accessible at www.ema.europa.eu

There may be a delay between the issuing of a marketing authorisation to a company and the product being placed on the market.

Changes to marketing authorisations

Food-producing animals

(1) Amoxycare LA suspension for Injection 15% w/v(Amoxicillin) (Norbrook Laboratories)

Withdrawal periods changed – Cattle: meat 28 days, milk 84 hours; pigs and sheep: meat 19 days.

(2) Betamox LA 150 mg/ml suspension for injection(Amoxicillin) (Norbrook Laboratories)

Withdrawal periods changed – …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Letters and notices
    BMJ Publishing Group Limited